Gedea Biotech: Funding, Investors & Team (Sep 2026)
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
Gedea Biotech has raised $1.3M across 1 funding round on record, the most recent an undisclosed round of $1.3M announced in May 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gedea Biotech Company Profile and Key Stats
Latest funding round on record: May 2023.
Gedea Biotech Funding Rounds
Gedea Biotech Founders and Leadership Team
Contact details for the Gedea Biotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Gedea Biotech Funding Compared to Other Biotechnology Startups
Gedea Biotech's latest round of $1.3M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gedea Biotech in Biotechnology and Lund
Companies Similar to Gedea Biotech
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Gedea Biotech Funding FAQs
What does Gedea Biotech do?
Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as well as providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
How much funding has Gedea Biotech raised?
Gedea Biotech has raised $1.3M across 1 round on record. The most recent is an undisclosed round of $1.3M announced in May 2023.
When did Gedea Biotech last raise funding?
Gedea Biotech's most recent funding round on record is an undisclosed round of $1.3M, announced in May 2023.
Who is the CEO of Gedea Biotech?
Annette Safholm is listed as CEO at Gedea Biotech.
Where is Gedea Biotech headquartered?
Gedea Biotech is based in Lund, Skane Lan, Sweden.
How many employees does Gedea Biotech have?
Gedea Biotech is in the 11-50 employee band.
How does Gedea Biotech's funding compare to other Biotechnology startups?
Gedea Biotech's latest round of $1.3M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Gedea Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gedea Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.